You are here
L2 DIAGNOSTICS LLC
UEI: GKA7VH5LFR25
# of Employees: 15
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
A serologic assay to measure successful Lyme borreliosis antibiotic therapy
Amount: $278,455.00DESCRIPTION (provided by applicant): Lyme disease, due to infection with the Ixodes tick-transmitted spirochete Borrelia burgdorferi, is the most common vector-borne disease in the United States, with ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
Bio-monitoring Methylene Diphenyl Diisocyanate (MDI) exposure and body burden
Amount: $211,466.00DESCRIPTION (provided by applicant): Exposure to isocyanate, the essential cross-linker for making polyurethane, is a leading cause of occupational asthma world-wide. Three major types of isocyanate ...
STTRPhase I2010Department of Health and Human Services National Institutes of Health -
EGFR Peptides as Vaccines in Anti-Tumor Immunity
Amount: $1,118,130.00DESCRIPTION (provided by applicant): Epidermal Growth Factor Receptor (EGFR) bearing tumors remain as one of the most insidious and difficult to treat human malignancies, affecting thousands of indivi ...
STTRPhase II2010Department of Health and Human Services National Institutes of Health -
Therapeutic Inhibition of MIF in Rheumatoid Arthritis
Amount: $239,686.00DESCRIPTION (provided by applicant): The long-term goal of this project is a small molecule therapeutic of benefit to patients with rheumatoid arthritis (RA), which will act by reducing the inflammat ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
New Serodiagnostics for Isocyanate Exposure, A Major Cause of Occupational Asthma
Amount: $710,274.00DESCRIPTION (provided by applicant): Through a Phase I STTR grant, we developed a blood-based enzyme-linked immunosorbant assay (ELISA) to fulfill an important unmet need in public health efforts agai ...
STTRPhase II2009Department of Health and Human Services National Institutes of Health -
Small Molecule West Nile Virus Inhibitors
Amount: $200,994.00DESCRIPTION (provided by applicant): Due to its high prevalence and its ability to cause severe disease in humans for which treatments are unavailable, West Nile (WN) virus has become an important pub ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Glioma Therapeutics Targeting Glioma Pathogenesis-related Protein
Amount: $219,461.00DESCRIPTION (provided by applicant): Gliomas are malignant tumors that arise from glial cells in the central nervous system and are among the deadliest of human cancers. These tumors are notorious for ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Nanoparticle-based vaccines against flaviviruses
Amount: $591,408.00DESCRIPTION (provided by applicant): The objective of this proposal is to develop nanoparticle-based vaccines against West Nile virus. West Nile virus is an emerging human pathogen and a model for ot ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Lyme Disease Diagnostics Using In Vivo Expressed Borrelia Burgdorferi Antigens
Amount: $275,834.00DESCRIPTION (provided by applicant): Lyme disease, due to infection with the Ixodes tick-transmitted spirochete Borrelia burgdorferi, is the most common vector-borne disease in the United States, with ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Tick Midgut Thrombin Inhibitor as a Vaccine Target
Amount: $213,408.00DESCRIPTION (provided by applicant): We seek in this proposal to develop a tick vaccine to block tick feeding and pathogen transmission to the vertebrate host. Ticks can harbor bacterial, viral and pr ...
STTRPhase I2008Department of Health and Human Services National Institutes of Health
